These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 1329231)
1. The European Organization for Research and Treatment of Cancer experience with teniposide: preliminary results of a randomized study in non-small cell lung cancer. Giaccone G; Splinter TA; Kirkpatrick A; Dalesio O; van Zandwijk N; McVie JG Semin Oncol; 1992 Apr; 19(2 Suppl 6):98-102. PubMed ID: 1329231 [TBL] [Abstract][Full Text] [Related]
2. Results of the phase II EORTC study comparing paclitaxel/cisplatin with teniposide/cisplatin in patients with non-small cell lung cancer. EORTC Lung Cancer Cooperative Group. Postmus PE; Giaccone G; Debruyne C; Sahmoud T; Splinter TA; van Zandwijk N Semin Oncol; 1996 Oct; 23(5 Suppl 12):10-3. PubMed ID: 8941404 [TBL] [Abstract][Full Text] [Related]
3. Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer. von Pawel J; Wagner H; Niederle N; Heider A; Koschel G; Hecker D; Hanske M Semin Oncol; 1996 Dec; 23(6 Suppl 16):47-50. PubMed ID: 9007121 [TBL] [Abstract][Full Text] [Related]
4. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group. Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975 [TBL] [Abstract][Full Text] [Related]
5. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy. Hainsworth JD; Greco FA Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970 [TBL] [Abstract][Full Text] [Related]
6. A randomized trial of two platinum combinations in patients with advanced non-small cell lung cancer: a preliminary report. European Organization for the Research and Treatment of Cancer--Lung Cancer Working Party. Klastersky J; Sculier JP; Dabouis G; Bureau G; Libert P; Ravez P; Vandermoten G; Thiriaux J; Lecomte J; Cordier R Semin Oncol; 1990 Feb; 17(1 Suppl 2):20-4. PubMed ID: 2154855 [TBL] [Abstract][Full Text] [Related]
7. European experience with ifosfamide in non-small cell lung cancer. Drings P Semin Oncol; 1989 Feb; 16(1 Suppl 3):22-30. PubMed ID: 2539645 [TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer. Jiang J; Liang X; Zhou X; Huang R; Chu Z Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133 [TBL] [Abstract][Full Text] [Related]
9. Cisplatin/paclitaxel vs cisplatin/teniposide for advanced non-small-cell lung cancer. The EORTC Lung Cancer Cooperative Group. The European Organization for Research and Treatment of Cancer. Giaccone G; Postmus PE; Splinter TA; Diaz-Puente M; Van Zandwijk N; Scagliotti G; Ardizzoni A; Van Meerbeeck J; Debruyne C Oncology (Williston Park); 1997 Apr; 11(4 Suppl 3):11-4. PubMed ID: 9144684 [TBL] [Abstract][Full Text] [Related]
10. Preliminary results of a phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer. Sørensen JB; Wedervang K; Dombernowsky P Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-18-S12-20. PubMed ID: 9331114 [TBL] [Abstract][Full Text] [Related]
11. The expanding role of cisplatin in the treatment of non-small-cell lung cancer. Bunn PA Semin Oncol; 1989 Aug; 16(4 Suppl 6):10-21. PubMed ID: 2548280 [TBL] [Abstract][Full Text] [Related]
12. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study. Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138 [TBL] [Abstract][Full Text] [Related]
14. The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer. Bunn PA Semin Oncol; 1996 Dec; 23(6 Suppl 16):18-25. PubMed ID: 9007116 [TBL] [Abstract][Full Text] [Related]
15. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design. Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772 [TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer. Hotta K; Matsuo K; Ueoka H; Kiura K; Tabata M; Tanimoto M J Clin Oncol; 2004 Oct; 22(19):3852-9. PubMed ID: 15326195 [TBL] [Abstract][Full Text] [Related]
17. Teniposide in the treatment of non-small cell lung carcinoma. Giaccone G; Donadio M; Ferrati P; Bonardi G; Ciuffreda L; Bagatella M; Calciati A Cancer Treat Rep; 1987 Jan; 71(1):83-5. PubMed ID: 3024829 [TBL] [Abstract][Full Text] [Related]
18. [Comparision of high dose impulsion and low dose density chemotherapeutic regimens with paclitaxel plus cisplatin in advanced NSCLC]. Hua XM; Ren XW; Liu FL; Liu Y; Zhang CJ; Li ZJ; Xu L; Liu JY; Liu YG Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):621-5. PubMed ID: 15634526 [TBL] [Abstract][Full Text] [Related]
19. [Recent changes in the management of advanced non-small cell lung cancer]. Kodama N; Kawahara M; Furuse K Gan To Kagaku Ryoho; 1994 Nov; 21(15):2564-70. PubMed ID: 7979414 [TBL] [Abstract][Full Text] [Related]
20. [Teniposide and cisplatin compared with etoposide and cisplatin for treatment of small cell lung cancer]. Fan Y; Huang ZY; Zhang YP; Sun L Ai Zheng; 2002 Dec; 21(12):1368-71. PubMed ID: 12520751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]